![Kai Lin Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kai Lin Liu
Director de Inversiones en Beijing Biostar Pharmaceuticals Co. Ltd. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 años |
Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 años |
Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
Quan Zhou | F | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 15 años |
Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 años |
Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 años |
Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 años |
Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 años |
Yu Li Zhang | M | 59 |
Nankai University
| 16 años |
Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
Fei Peng | M | 50 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Wen Feng Shi | M | 46 |
Nankai University
| 4 años |
Wen Quan Wang | M | 44 |
Nankai University
| 4 años |
Yi Xin | F | 39 |
Nankai University
| 4 años |
Yan Fang Xu | M | 56 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
Li Guan | M | 47 |
Nankai University
| 2 años |
Yong Sheng Zhao | M | 37 |
Nankai University
| 4 años |
Ze Lin Zhang | M | 49 |
Nankai University
| 2 años |
Ying Zhong Tan | M | 62 |
Nankai University
| 1 años |
Ze Guang Li | M | 44 |
Nankai University
| 3 años |
Yang Xu | M | 45 |
Nankai University
| 1 años |
Wei Xie | M | 50 |
Nankai University
| 4 años |
Rui Wang | F | 39 |
Nankai University
| 4 años |
Ying JIe Li | M | 40 |
Nankai University
| 2 años |
Ting Li | F | 35 |
Nankai University
| 4 años |
Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
![]() Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 años |
Dong Hong Zhang | M | 49 |
Nankai University
| 3 años |
Chang Ying Xu | M | 52 |
Nankai University
| 2 años |
Lili Zhang | F | - |
Nankai University
| 4 años |
Olivia Lingyun Zhang | F | - |
Nankai University
| 4 años |
Chong Fu He | M | 46 |
Nankai University
| 2 años |
Zhao Ning Li | M | 46 |
Nankai University
| 1 años |
Zhong Bin Wang | M | 42 |
Nankai University
| 2 años |
Dai Ping Chen | M | 41 |
Nankai University
| 4 años |
Min Zeng | F | - |
Nankai University
| 1 años |
Dong Xu Sun | M | 39 |
Nankai University
| 4 años |
Ye Sheng | M | 50 |
Nankai University
| 4 años |
Yu Qiang Zhang | M | 62 |
Nankai University
| 2 años |
Yong Gang Gao | M | 59 |
Nankai University
| 3 años |
Zhi Hua Zhang | M | 67 |
Nankai University
| 2 años |
Bin Zhang | M | 45 |
Nankai University
| 3 años |
Chang Hong Bai | M | 59 |
Nankai University
| 1 años |
Fei Ming Liu | M | 55 |
Nankai University
| 3 años |
Tian Hua Zhang | M | 60 |
Nankai University
| 2 años |
Yong Liang Wang | M | 59 |
Nankai University
| 4 años |
Zhen Hua Chen | M | - |
Nankai University
| 4 años |
Xiang Peng Bo | M | 39 |
Nankai University
| 1 años |
Xin Guang Yan | M | 50 |
Nankai University
| 1 años |
Zhi Yong Wang | M | 52 |
Nankai University
| 1 años |
Xiao Xuan Li | M | 50 |
Nankai University
| 2 años |
Zou Ruiyang | M | 38 |
Nankai University
| 4 años |
Wei Fang | M | 44 |
Nankai University
| 2 años |
Ray Cao | M | - |
Nankai University
| 4 años |
Ping Yan Bai | M | 52 |
Nankai University
| 2 años |
Wei Hong Yang | M | 55 |
Nankai University
| 3 años |
Shi Chen | M | 40 |
Nankai University
| 2 años |
Simon Dazhong Lu | M | 55 |
Nankai University
| 3 años |
Jia Chen | M | 43 |
Nankai University
| 4 años |
Da Cheng | M | 47 |
Nankai University
| 4 años |
Dong Xue Liu | M | 38 |
Nankai University
| 4 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
China | 63 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Kai Lin Liu
- Red Personal